Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Anticoagulants' Safety and Effectiveness in General Practice: A Nationwide Prospective Cohort Study.

Frappé P, Cogneau J, Gaboreau Y, Abenhaïm N, Bayen M, Guichard C, Jacquet JP, Lacoin F, Liébart S, Bertoletti L, Bosson JL; CACAO study investigators.

Ann Fam Med. 2020 Mar;18(2):131-138. doi: 10.1370/afm.2495.

2.

Direct oral anticoagulants: Still too early for prime time after pulmonary endarteriectomy?

Bertoletti L, Jaïs X, Bezzeghoud S, Delavenne X.

J Thromb Haemost. 2020 Mar;18(3):758-759. doi: 10.1111/jth.14706. No abstract available.

PMID:
32112534
3.

DOAC compared to LMWH in the treatment of cancer related-venous thromboembolism: a systematic review and meta-analysis.

Mai V, Tanguay VF, Guay CA, Bertoletti L, Magnan S, Turgeon AF, Lacasse Y, Lega JC, Provencher S.

J Thromb Thrombolysis. 2020 Feb 12. doi: 10.1007/s11239-020-02055-1. [Epub ahead of print]

PMID:
32052314
4.

Autonomic cardiovascular adaptations to acute head-out water immersion, head-down tilt and supine position.

Chouchou F, Pichot V, Costes F, Guillot M, Barthélémy JC, Bertoletti L, Roche F.

Eur J Appl Physiol. 2020 Feb;120(2):337-347. doi: 10.1007/s00421-019-04278-4. Epub 2019 Dec 7.

PMID:
31813043
5.

What's next after the clot? Residual pulmonary vascular obstruction after pulmonary embolism: From imaging finding to clinical consequences.

Bonnefoy PB, Margelidon-Cozzolino V, Catella-Chatron J, Ayoub E, Guichard JB, Murgier M, Bertoletti L.

Thromb Res. 2019 Dec;184:67-76. doi: 10.1016/j.thromres.2019.09.038. Epub 2019 Oct 28. Review.

PMID:
31710860
6.

"Rehab for all!" Is it too early in pulmonary arterial hypertension?

Bertoletti L, Bouvaist H, Tromeur C, Bezzeghoud S, Dauphin C, Enache I, Bourdin A, Seronde MF, Montani D, Turquier S, Pison C; FONCE-HTAP investigators; Steering committee.

Eur Respir J. 2019 Nov 7;54(5). pii: 1901558. doi: 10.1183/13993003.01558-2019. Print 2019 Nov. No abstract available.

PMID:
31699779
7.

[What route of care to propose to patients suffering from pulmonary embolism ? Who to treat as an outpatient ?]

Bertoletti L, Delluc A, Frappé P, Roy PM, Sanchez O; Recommandations de bonne pratique pour la prise en charge de la MVTE.

Rev Mal Respir. 2019 Oct 11. pii: S0761-8425(19)30212-8. doi: 10.1016/j.rmr.2019.06.001. [Epub ahead of print] French. No abstract available.

PMID:
31611027
8.

Chronic thromboembolic pulmonary hypertension suspicion after pulmonary embolism in cancer patients.

Catella-Chatron J, Merah A, De Magalhaes E, Moulin N, Accassat S, Duvillard C, Mismetti P, Bertoletti L.

Respir Med Res. 2019 Nov;76:34-37. doi: 10.1016/j.resmer.2019.08.002. Epub 2019 Aug 27.

PMID:
31527015
9.

Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis.

Lurkin A, Derex L, Fambrini A, Bertoletti L, Epinat M, Mismetti P, Dargaud Y.

Cerebrovasc Dis. 2019;48(1-2):32-37. doi: 10.1159/000502454. Epub 2019 Sep 3.

PMID:
31480062
10.

In vitro assessment of P-gp and BCRP transporter-mediated drug-drug interactions of riociguat with direct oral anticoagulants.

Jacqueroux E, Mercier C, Margelidon-Cozzolino V, Hodin S, Bertoletti L, Delavenne X.

Fundam Clin Pharmacol. 2020 Feb;34(1):109-119. doi: 10.1111/fcp.12504. Epub 2019 Aug 28.

PMID:
31411766
11.

Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC.

Tardy B, Chalayer E, Kamphuisen PW, Ni Ainle F, Verhamme P, Varlet MN, Chauleur C, Rodger M, Merah A, Buchmuller A, Bistervels I, De Sancho MT, Middeldorp S, Bertoletti L; SSC Subcommittee on Control of Anticoagulation of the ISTH.

J Thromb Haemost. 2019 Nov;17(11):1979-1988. doi: 10.1111/jth.14576. Epub 2019 Aug 12. No abstract available.

PMID:
31402557
12.

Avoiding disease mongering: A checklist for vascular physicians and researchers.

Frappé P, Haller DM, Roméas A, Bertoletti L, François M, Robert-Ebadi H, Righini M.

Thromb Res. 2019 Sep;181:120-123. doi: 10.1016/j.thromres.2019.08.001. Epub 2019 Aug 3. Review.

PMID:
31400622
13.

The Ottawa score performs poorly in cancer patients with incidental pulmonary embolism.

Mulder FI, Kraaijpoel N, Di Nisio M, Meyer G, Mahé I, Muñoz A, Bertoletti L, Biosca M, Maraveyas A, Büller HR, van Es N.

Thromb Res. 2019 Sep;181:59-63. doi: 10.1016/j.thromres.2019.07.005. Epub 2019 Jul 11.

PMID:
31352267
14.

Evaluation of the predictive value of the bleeding prediction score VTE-BLEED for recurrent venous thromboembolism.

Klok FA, Presles E, Tromeur C, Barco S, Konstantinides SV, Sanchez O, Pernod G, Raj L, Robin P, Le Roux PY, Hoffman C, Mélac S, Bertoletti L, Girard P, Laporte S, Mismetti P, Meyer G, Leroyer C, Couturaud F; PADIS‐PE Investigators.

Res Pract Thromb Haemost. 2019 May 25;3(3):364-371. doi: 10.1002/rth2.12214. eCollection 2019 Jul.

15.

Synergistic application of pulmonary 18F-FDG PET/HRCT and computer-based CT analysis with conventional severity measures to refine current risk stratification in idiopathic pulmonary fibrosis (IPF).

Fraioli F, Lyasheva M, Porter JC, Bomanji J, Shortman RI, Endozo R, Wan S, Bertoletti L, Machado M, Ganeshan B, Win T, Groves AM.

Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2023-2031. doi: 10.1007/s00259-019-04386-5. Epub 2019 Jul 8.

16.

[Recommendations for best practice in the management of venous thromboembolic disease in adults. Long version].

Sanchez O, Benhamou Y, Bertoletti L, Constans J, Couturaud F, Delluc A, Elias A, Fischer AM, Frappé P, Gendron N, Girard P, Godier A, Gut-Gobert C, Laporte S, Mahé I, Mauge L, Meneveau N, Meyer G, Mismetti P, Parent F, Pernod G, Quéré I, Revel MP, Roy PM, Salaün PY, Smadja DM, Sevestre MA.

Rev Mal Respir. 2019 Jul 4. pii: S0761-8425(19)30210-4. doi: 10.1016/j.rmr.2019.05.038. [Epub ahead of print] French. No abstract available.

PMID:
31280989
17.

Pulmonary hypertension due to pulmonary artery obstructions by malignant tumoral cells.

Murgier M, Forest F, Savale L, Ilie M, Bertoletti L.

Respir Med Res. 2019 Nov;76:10-12. doi: 10.1016/j.resmer.2019.04.006. Epub 2019 Apr 30. No abstract available.

PMID:
31254944
18.

Predictors for Residual Pulmonary Vascular Obstruction after Unprovoked Pulmonary Embolism: Implications for Clinical Practice-The PADIS-PE Trial.

Raj L, Robin P, Le Mao R, Presles E, Tromeur C, Sanchez O, Pernod G, Bertoletti L, Jego P, Leven F, Lemarié CA, Martin A, Planquette B, Le Roux PY, Salaun PY, Nonent M, Girard P, Lacut K, Melac S, Mismetti P, Laporte S, Meyer G, Leroyer C, Couturaud F; PADIS-PE Investigators.

Thromb Haemost. 2019 Sep;119(9):1489-1497. doi: 10.1055/s-0039-1692424. Epub 2019 Jun 23.

PMID:
31230343
19.

Erratum à « Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medicine (SFMV) » [J. Med. Vasc. 44 (2019) 28–70].

Quéré I, Elias A, Maufus M, Elias M, Sevestre MA, Galanaud JP, Bosson JL, Bura-Rivière A, Jurus C, Lacroix P, Zuily S, Diard A, Wahl D, Bertoletti L, Brisot D, Frappe P, Gillet JL, Ouvry P, Pernod G.

J Med Vasc. 2019 Jun;44(4):307-308. doi: 10.1016/j.jdmv.2019.04.009. Epub 2019 May 15. French. No abstract available.

PMID:
31213305
20.

Extended Anticoagulation for VTE: A Systematic Review and Meta-Analysis.

Mai V, Guay CA, Perreault L, Bonnet S, Bertoletti L, Lacasse Y, Jardel S, Lega JC, Provencher S.

Chest. 2019 Jun;155(6):1199-1216. doi: 10.1016/j.chest.2019.02.402.

PMID:
31174635
21.

Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry.

Murgier M, Bertoletti L, Darmon M, Zeni F, Valle R, Del Toro J, Llamas P, Mazzolai L, Villalobos A, Monreal M; RIETE Investigators.

Int J Cardiol. 2019 Sep 15;291:121-126. doi: 10.1016/j.ijcard.2019.04.083. Epub 2019 May 21.

PMID:
31147192
22.

Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study.

Kraaijpoel N, Bleker SM, Meyer G, Mahé I, Muñoz A, Bertoletti L, Bartels-Rutten A, Beyer-Westendorf J, Porreca E, Boulon C, van Es N, Iosub DI, Couturaud F, Biosca M, Lerede T, Lacroix P, Maraveyas A, Aggarwal A, Girard P, Büller HR, Di Nisio M; UPE investigators.

J Clin Oncol. 2019 Jul 10;37(20):1713-1720. doi: 10.1200/JCO.18.01977. Epub 2019 May 22.

PMID:
31116676
23.

Indications and potential pitfalls of anticoagulants in pulmonary hypertension: Would DOACs become a better option than VKAs?

Margelidon-Cozzolino V, Delavenne X, Catella-Chatron J, De Magalhaes E, Bezzeghoud S, Humbert M, Montani D, Bertoletti L.

Blood Rev. 2019 Sep;37:100579. doi: 10.1016/j.blre.2019.05.003. Epub 2019 May 15. Review.

PMID:
31113643
24.

Cancer incidence in patients with pre-capillary pulmonary hypertension.

Bravos E, Cottin V, Dauphin C, Bouvaist H, Traclet J, Trésorier R, Margelidon-Cozzolino V, Bezzeghoud S, Ahmad K, Accassat S, De Magalhaes E, Mornex JF, Pison C, Bertoletti L.

J Heart Lung Transplant. 2019 Jul;38(7):778-780. doi: 10.1016/j.healun.2019.03.007. Epub 2019 Mar 15. No abstract available.

PMID:
30962146
25.

Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis.

Mai V, Bertoletti L, Cucherat M, Jardel S, Grange C, Provencher S, Lega JC.

PLoS One. 2019 Apr 1;14(4):e0214134. doi: 10.1371/journal.pone.0214134. eCollection 2019.

26.

Direct oral anticoagulants for venous thromboembolism prophylaxis in critically ill patients: where do we go from here?

Bertoletti L, Murgier M, Stelfox HT.

Intensive Care Med. 2019 Apr;45(4):549-551. doi: 10.1007/s00134-019-05605-1. Epub 2019 Mar 25. No abstract available.

PMID:
30911805
27.

Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism.

van der Pol LM, Tromeur C, Bistervels IM, Ni Ainle F, van Bemmel T, Bertoletti L, Couturaud F, van Dooren YPA, Elias A, Faber LM, Hofstee HMA, van der Hulle T, Kruip MJHA, Maignan M, Mairuhu ATA, Middeldorp S, Nijkeuter M, Roy PM, Sanchez O, Schmidt J, Ten Wolde M, Klok FA, Huisman MV; Artemis Study Investigators.

N Engl J Med. 2019 Mar 21;380(12):1139-1149. doi: 10.1056/NEJMoa1813865.

PMID:
30893534
28.

[Recommendations of good practice for the management of thromboembolic venous disease in adults. Short version].

Sanchez O, Benhamou Y, Bertoletti L, Constant J, Couturaud F, Delluc A, Elias A, Fischer AM, Frappé P, Gendron N, Girard P, Godier A, Gut-Gobert C, Laporte S, Mahé I, Mauge L, Meneveau N, Meyer G, Mismetti P, Parent F, Pernod G, Quéré I, Revel MP, Roy PM, Salaün PY, Smadja DM, Sevestre MA.

Rev Mal Respir. 2019 Feb;36(2):249-283. doi: 10.1016/j.rmr.2019.01.003. Epub 2019 Feb 22. French. No abstract available.

PMID:
30799126
29.

[Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medicine (SFMV)].

Quéré I, Elias A, Maufus M, Elias M, Sevestre MA, Galanaud JP, Bosson JL, Bura-Rivière A, Jurus C, Lacroix P, Zuily S, Diard A, Wahl D, Bertoletti L, Brisot D, Frappe P, Gillet JL, Ouvry P, Pernod G.

J Med Vasc. 2019 Feb;44(1):e1-e47. doi: 10.1016/j.jdmv.2018.12.178. Epub 2019 Feb 2. French. No abstract available.

PMID:
30770089
30.

Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medicine (SFMV).

Quéré I, Elias A, Maufus M, Elias M, Sevestre MA, Galanaud JP, Bosson JL, Bura-Rivière A, Jurus C, Lacroix P, Zuily S, Diard A, Wahl D, Bertoletti L, Brisot D, Frappe P, Gillet JL, Ouvry P, Pernod G.

J Med Vasc. 2019 Feb;44(1):28-70. doi: 10.1016/j.jdmv.2018.12.003. Epub 2019 Jan 23. No abstract available. Erratum in: J Med Vasc. 2019 Jun;44(4):307-308.

PMID:
30770082
31.

The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease.

Jiménez D, Agustí A, Monreal M, Otero R, Huisman MV, Lobo JL, Quezada A, Jara-Palomares L, Hernando A, Tabernero E, Marcos P, Ruiz-Artacho P, Ballaz A, Bertoletti L, Couturaud F, Yusen R; SLICE investigators.

Clin Cardiol. 2019 Mar;42(3):346-351. doi: 10.1002/clc.23161. Epub 2019 Feb 25.

32.

Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial.

Couturaud F, Pernod G, Presles E, Duhamel E, Jego P, Provost K, Pan-Petesch B, Sollier CBD, Tromeur C, Hoffmann C, Bressollette L, Lorillon P, Girard P, Le Moigne E, Le Hir A, Guégan M, Laporte S, Mismetti P, Lacut K, Bosson JL, Bertoletti L, Sanchez O, Meyer G, Leroyer C, Mottier D; “PADIS-DVT” investigators.

Haematologica. 2019 Jul;104(7):1493-1501. doi: 10.3324/haematol.2018.210971. Epub 2019 Jan 3.

33.

Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial.

Barco S, Russo M, Vicaut E, Becattini C, Bertoletti L, Beyer-Westendorf J, Bouvaist H, Couturaud F, Danays T, Dellas C, Duerschmied D, Empen K, Ferrari E, Galiè N, Jiménez D, Klok FA, Kostrubiec M, Kozak M, Kupatt C, Lang IM, Lankeit M, Meneveau N, Palazzini M, Pruszczyk P, Rugolotto M, Salvi A, Sanchez O, Schellong S, Sobkowicz B, Meyer G, Konstantinides SV.

Clin Res Cardiol. 2019 Jul;108(7):772-778. doi: 10.1007/s00392-018-1405-1. Epub 2018 Dec 18.

34.

[Risk factors for thromboembolic disease in young women-the role of hormones].

Tromeur C, Le Mao R, Jego P, El-Kouri D, Gruel Y, Pan-Petesch B, Bertoletti L, Morange PE, Lemoigne E, Paleiron N, Leroyer C, Couturaud F.

Rev Mal Respir. 2019 Feb;36(2):219-226. doi: 10.1016/j.rmr.2018.05.013. Epub 2018 Oct 11. French.

PMID:
30318429
35.

Ruling out deep vein thrombosis in patients with superficial vein thrombosis: external validation of the ICARO score.

Frappé P, Brosse Q, Seffert B, Décousus H, Bertoletti L; STEPH Study Group.

J Thromb Thrombolysis. 2019 Jan;47(1):96-101. doi: 10.1007/s11239-018-1754-7.

PMID:
30317413
36.

Benefit of Risk Score-Guided Prophylaxis in Pregnant Women at Risk of Thrombotic Events: A Controlled Before-and-After Implementation Study.

Chauleur C, Gris JC, Laporte S, Chapelle C, Bertoletti L, Equy V, Gaucherand P, Bazan E, Dupuis O, Gallot D, Mismetti P; STRATHEGE Investigators and The STRATHEGE Group.

Thromb Haemost. 2018 Sep;118(9):1564-1571. doi: 10.1055/s-0038-1668524. Epub 2018 Aug 13.

PMID:
30103244
37.

Screening cancer after venous thromboembolism: How many abnormal tests before diagnosing cancer? An analysis of practice.

Duvillard C, De Magalhaes E, Moulin N, Accassat S, Mismetti P, Bertoletti L.

Presse Med. 2018 Jul - Aug;47(7-8 Pt 1):e99-e106. doi: 10.1016/j.lpm.2018.01.026. Epub 2018 Jul 31.

PMID:
30075951
38.

Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP).

Decousus H, Bourmaud A, Fournel P, Bertoletti L, Labruyère C, Presles E, Merah A, Laporte S, Stefani L, Piano FD, Jacquin JP, Meyer G, Chauvin F; ONCOCIP Investigators.

Blood. 2018 Aug 16;132(7):707-716. doi: 10.1182/blood-2018-03-837153. Epub 2018 Jul 6.

PMID:
29980524
39.

Prognosis of venous thromboembolism in orthopaedic surgery or trauma patients and use of thromboprophylaxis.

Gutiérrez Guisado J, Trujillo-Santos J, Arcelus JI, Bertoletti L, Fernandez-Capitán C, Valle R, Hernandez-Hermoso JA, Erice Calvo-Sotelo A, Nieto JA, Monreal M; en nombre de los investigadores del estudio RIETE.

Rev Clin Esp. 2018 Nov;218(8):399-407. doi: 10.1016/j.rce.2018.04.018. English, Spanish.

PMID:
29929734
40.

Outcomes following a negative computed tomography pulmonary angiography according to pulmonary embolism prevalence: a meta-analysis of the management outcome studies.

Belzile D, Jacquet S, Bertoletti L, Lacasse Y, Lambert C, Lega JC, Provencher S.

J Thromb Haemost. 2018 Jun;16(6):1107-1120. doi: 10.1111/jth.14021. Epub 2018 May 17.

PMID:
29645405
41.

In Vitro Assessment of Pharmacokinetic Drug-Drug Interactions of Direct Oral Anticoagulants: Type 5-Phosphodiesterase Inhibitors Are Inhibitors of Rivaroxaban and Apixaban Efflux by P-Glycoprotein.

Margelidon-Cozzolino V, Hodin S, Jacqueroux E, Delézay O, Bertoletti L, Delavenne X.

J Pharmacol Exp Ther. 2018 Jun;365(3):519-525. doi: 10.1124/jpet.117.245993. Epub 2018 Mar 23.

PMID:
29572341
42.

Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy.

Otero R, Bertoletti L, Muriel A, Siniscalchi C, Jimenez C, Luis Lobo J, Kigitovica D, Quintavalla R, Rocci A, Jara-Palomares L, Monreal M; RIETE Investigators.

Eur Respir J. 2018 Apr 19;51(4). pii: 1702576. doi: 10.1183/13993003.02576-2017. Print 2018 Apr. No abstract available.

43.

Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events-a meta-analysis.

Trone JC, Ollier E, Chapelle C, Bertoletti L, Cucherat M, Mismetti P, Magné N, Laporte S.

Ann Oncol. 2018 Apr 1;29(4):803-811. doi: 10.1093/annonc/mdy035.

44.

Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review.

Bertoletti L, Benhamou Y, Béjot Y, Marechaux S, Cheggour S, Aleil B, Lellouche N, Dillinger JG, Delluc A.

Blood Rev. 2018 Jul;32(4):272-279. doi: 10.1016/j.blre.2018.01.002. Epub 2018 Apr 20. Review.

PMID:
29402471
45.

Predictors of Post-Thrombotic Ulcer after Acute DVT: The RIETE Registry.

Galanaud JP, Bertoletti L, Amitrano M, Fernández-Capitán C, Pedrajas JM, Rosa V, Barrón M, Lorenzo A, Madridano O, Quéré I, Kahn SR, Prandoni P, Monreal M; RIETE registry investigators.

Thromb Haemost. 2018 Feb;118(2):320-328. doi: 10.1160/TH17-08-0598. Epub 2018 Jan 29.

PMID:
29378357
46.

Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial.

Tromeur C, Sanchez O, Presles E, Pernod G, Bertoletti L, Jego P, Duhamel E, Provost K, Parent F, Robin P, Deloire L, Leven F, Mingant F, Bressollette L, Le Roux PY, Salaun PY, Nonent M, Pan-Petesch B, Planquette B, Girard P, Lacut K, Melac S, Mismetti P, Laporte S, Meyer G, Mottier D, Leroyer C, Couturaud F; PADIS-PE Investigators18.

Eur Respir J. 2018 Jan 4;51(1). pii: 1701202. doi: 10.1183/13993003.01202-2017. Print 2018 Jan.

47.

Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism.

Chai-Adisaksopha C, Iorio A, Crowther MA, de Miguel J, Salgado E, Zdraveska M, Fernández-Capitán C, Nieto JA, Barillari G, Bertoletti L, Monreal M; RIETE investigators.

Am J Med. 2018 Apr;131(4):430-437. doi: 10.1016/j.amjmed.2017.11.042. Epub 2017 Dec 20.

PMID:
29274307
48.

Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients.

Dillinger JG, Aleil B, Cheggour S, Benhamou Y, Béjot Y, Marechaux S, Delluc A, Bertoletti L, Lellouche N.

Arch Cardiovasc Dis. 2018 Feb;111(2):85-94. doi: 10.1016/j.acvd.2017.04.008. Epub 2017 Oct 2. Review.

49.

Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score.

Bertoletti L, Robin P, Jara-Palomares L, Tromeur C, Pastre J, Prevot-Bitot N, Mouneh T, Le Gal G, Salaun PY; MVTEP investigators.

J Thromb Haemost. 2017 Nov;15(11):2184-2187. doi: 10.1111/jth.13842. Epub 2017 Oct 24.

50.

Practical issues in suspected venous thrombosis in general practice: A multicentre prospective cohort in primary care.

Bruel S, Ginzarly M, Bertoletti L, Fayard P, Chapelier E, Seffert B, Simon-Momège B, Frappé P; GUSTAVE investigators.

Thromb Res. 2017 Oct;158:19-21. doi: 10.1016/j.thromres.2017.08.002. Epub 2017 Aug 6. No abstract available.

PMID:
28800412

Supplemental Content

Loading ...
Support Center